UBS lowered its price target on AmBev stock, while AI stocks are noted to be benefiting from the Trump-era tariffs.
3 reports, 1 independent
Updated Aug 26
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS lowered its price target on AmBev stock, while AI stocks are noted to be benefiting from the Trump-era tariffs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AmBev's volume growth was driven by positive performance in Brazil, while market assessments noted that tariffs might affect AI stocks, not AmBev.Sub-event
UBS lowers AmBev target; AI stocks benefit from Trump-era tariffs.1 source
Keep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
AmBev
Brazilian brewing company
Nothing else this week.
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- Barclays raised its price target for Okta, noting that AI stocks are benefiting from the onshoring trend and Trump-era tariffs.
- Tariffs benefit undervalued AI stocks, and Jim Cramer expressed bullish sentiment regarding Texas Roadhouse.
- Goldman Sachs and Zeta Interactive noted that tariffs and onshoring benefit AI stocks, citing accelerated Q2 growth and raising price targets.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
- Jim Cramer mentioned AI stocks benefiting from Trump tariffs, with Planet Fitness also involved in the discussion.
Coverage
Newest first; wire copies grouped- Insider MonkeyUBS Lowers the PT on Ambev S.A. (ABEV), Keeps a Neutral Rating Ambev S.A. (NYSE:ABEV) is one of the Most Undervalued International Stocks According to Analysts. On August 20, UBS analyst Rodrigo Alca
- Insider MonkeyUBS Lowers PT on Ambev S.A. (ABEV) to $2.20 from $2.50, Keeps a Neutral Rating Ambev S.A. (NYSE:ABEV) is one of the best stocks under $10 to buy right now. On August 20, UBS analyst Rodrigo Alcantara
- Insider MonkeyBank of America Securities Maintains a Hold Rating on Ambev S.A. (ABEV) Ambev S.A. (NYSE:ABEV) is one of the best NYSE stocks to buy under $20. In a report released on August 1, Isabella Simonato fro